Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The study suggests that hypothyroidism may cause alopecia areata.

Regulatory T cells are essential for normal and improved wound healing in mice.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.